% | $
Quotes you view appear here for quick access.

Compugen Ltd. (CGEN) Message Board

  • unbearibull unbearibull Sep 10, 2010 3:19 PM Flag

    Computational drug design technology

    No - it's not CGEN...

    For those who like this approach check out PolyMedix (PYMX). Their entire pipeline was designed by a computational drug design technology licensed from the University of Pennsylvania. The license is exclusive and granted in perpetuity.

    From a Roth Capital research report...

    "We believe PolyMedix's defensin mimetic program offers the potential to revolutionize the way bacterial infections are currently being treated. Given its broad applicability to both gram positive as well as gram negative bacteria, the market potential could reach well into the billions of dollars, if the drug continues to perform as it has in subsequent clinical testing. "

    more here...

    PYMX will be making 5 presentations at the Rodman & Renshaw Global Investment Conference on Sept 13 @ 12:30 PM.

    link to the webcast...

5.80Oct 25 4:00 PMEDT